BIRC5 and hepatocellular carcinoma: Notably, suppression of both miRNAs in doxorubicin-treated L02 and Hep3B also reduced mRNA levels of Survivin, an apoptotic inhibitor extensively associated with HCC proliferation [54], progression [55], and patient prognosis [56] (Fig 5A).